China-based WuXi Biologics is set to construct a biologics drug substance manufacturing facility worth about £285m in Dundalk, Ireland, which could create more than 700 jobs.
The manufacturing site will feature several single-use bioreactors for commercial biomanufacturing – image courtesy of WuXi Biologics. The construction of the company’s first site outside of China is supported by the Irish Government through the Industrial Development Authority. WuXi offers biologics platforms for the discovery, development and manufacture of biologics from…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
